Doximity, Inc.
NYSE:DOCSMedical - Healthcare Information Services
-$0.09 today
- Market cap
- $5.47B
- Beta
- 1.29
- P/E (TTM)
- 19.2
- EPS (TTM)
- $1.06
Volume 2.27M
Average 3.89M
DOCS Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Doximity, Inc.NYSE: DOCS
Deferred Revenue · Q2 FY2027 · quarter ended Sep 2026
Deferred revenue broadly unchanged from a year ago
Deferred revenue stood at $100.23M at the end of Q2 FY2027, up 0.2% from a year earlier and down 8.1% from the prior quarter. Over 3 fiscal years it compounded at +0.3% a year.
Context
- Deferred revenue amounted to 9.2% of total assets at the end of Q2 FY2027, up 1.2 pp from a year earlier.
- Deferred revenue increased in 1 of the last 3 fiscal years.
What to watch
Whether deferred revenue keeps rising in the next quarterly balance sheet after a +0.2% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2026
- 106.05M USD
- Year-over-year change
- -7.2%
- 4-year CAGR
- +5.7%
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 106.05M | -7.2% |
| FY2025 | 2025-03-31 | 114.29M | +15.3% |
| FY2024 | 2024-03-31 | 99.15M | -5.8% |
| FY2023 | 2023-03-31 | 105.24M | +23.9% |
| FY2022 | 2022-03-31 | 84.91M | — |
Deferred Revenue vs competitors
How DOCS compares with its peers on the latest reported figures
- DOCS's Sep 2026 deferred revenue of $100.23M is the 4th highest of the 10 companies compared; the peer median is $38.1M.
- Its year-over-year change of +0.2% is the 4th highest of 6, against a peer median of +2.4%.
- Deferred revenue amounts to 9.2% of total assets for DOCS, versus a peer median of 1.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $1.6B | +5.9% | +0.9% | 9.8% | |
| Jun 2026 | $596M | +7.0% | +3.6% | 4.2% | |
| Jul 2026 | $129.6M | +2.4% | +11.0% | 1.0% | |
| Sep 2026 | $100.23M | +0.2% | +0.3% | 9.2% | |
| Sep 2026 | $85.93M | -14.6% | +29.4% | 3.5% | |
| Sep 2026 | $38.1M | -18.7% | +42.9% | 2.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jul 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jul 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding DOCS) | $38.1M | +2.4% | +11.0% | 1.0% | |
Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 112.81M | 158.03M | 96.79M | 209.61M | 219.18M |
| Short-term Investments | 685.3M | 682.97M | 666.12M | 706.05M | 529.42M |
| Net Receivables | 81.07M | 107.05M | 101.33M | 128.35M | 144.78M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.51M | 27.41M | 48.71M | 44.6M | 50.88M |
| Total Current Assets | 904.14M | 975.45M | 912.94M | 1.09B | 944.26M |
| Property, Plant & Equipment (Net) | 9.58M | 25.1M | 24.65M | 22.54M | 25.22M |
| Goodwill | 18.92M | 67.94M | 67.94M | 67.94M | 84.97M |
| Intangible Assets | 7.91M | 31.84M | 27.32M | 23.07M | 35.33M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 48.56M | 34.91M | 45.07M | 60.01M | 31.98M |
| Other Non-current Assets | 2.26M | 1.65M | 1.46M | 2.12M | 1.92M |
| Total Non-current Assets | 87.22M | 161.44M | 166.43M | 175.69M | 179.42M |
| Total Assets | 991.36M | 1.14B | 1.08B | 1.26B | 1.12B |
| Account Payables | 463K | 1.27M | 2.25M | 1.36M | 4.01M |
| Short-term Debt | 0 | 0 | 0 | 0 | 2.11M |
| Tax Payables | 785K | 1.5M | 14.02M | 1.36M | 0 |
| Deferred Revenue | 84.91M | 105.24M | 99.15M | 114.29M | 106.05M |
| Other Current Liabilities | 4.88M | 11.92M | 14.77M | 12.06M | 42.8M |
| Total Current Liabilities | 111.28M | 139.51M | 147.25M | 156.26M | 154.97M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 78K | 198K | 211K | 280K | 400K |
| Other Non-current Liabilities | 956K | 17.18M | 18.12M | 14.96M | 9.4M |
| Total Non-current Liabilities | 1.48M | 31.27M | 30.73M | 25.43M | 17.88M |
| Total Liabilities | 112.76M | 170.77M | 177.98M | 181.68M | 172.85M |
| Common Stock | 192K | 194K | 187K | 189K | 183K |
| Retained Earnings | 191.11M | 217.86M | 79.99M | 186.89M | (51.06M) |
| Accumulated OCI | (15.29M) | (14.08M) | (2.66M) | 1.32M | 28K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 878.59M | 966.12M | 901.4M | 1.08B | 950.84M |
| Total Debt | 1.09M | 15.64M | 14.55M | 12.4M | 10.19M |
| Net Debt | (111.72M) | (142.39M) | (82.24M) | (197.22M) | (208.99M) |
Doximity, Inc.
NYSE:DOCS
Intrinsic Alpha fair value
Locked
Current Price
$30.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.